ESMO 2023 Industry Satellite Symposium

Accessing cutting-edge precision oncology through local testing

Monday 23 October 2023 | 13:00 – 14:30 CEST
Toledo Auditorium, Hall 3, IFEMA MADRID, Madrid, Spain

Timely and well-informed decisions are crucial in cancer care. A panel of speakers is addressing relevant questions in our symposium.

Add to Calendar Full Program

Dear Colleague

We are pleased to invite you

Myriad Genetics Industry Satellite Symposium will take place in Toledo Auditorium, Hall 3, IFEMA MADRID, Madrid, Spain on Monday, October 23, 2023. Explore precision oncology advancements, spotlighting genomic testing in women’s cancers.

Timely and well-informed decisions are crucial in cancer care. While numerous precision oncology tests are available to guide therapy decisions in ovarian and breast cancers, questions remain to be addressed.

If you want to have further information, please visit us at our booth #752 in Hall 7.

We look forward to welcoming you

Highlights of the Symposium

Participate in a dynamic and interactive session that shapes the future of cancer treatment. We look forward to welcoming you to Madrid both in person and virtually!

  • Engage in a thought-provoking dialogue on the interchangeability of HRD tests
  • Gain exclusive insights into the implementation of local LoE1A HRD testing for ovarian cancer patients within a center of excellence
  • Dive into the world of prospective real-world data, confirming the predictive and prognostic power of an early breast cancer second-generation test

Our panel of speakers

Prof. Pascal
Pujol

University Hospital Center
Cancer and Genetics
Montpellier, France

Prof. Carsten
Denkert

University Hospital
Pathology
Marburg, Germany

Prof. Benoît
You

Lyon-Sud Hospital
Medical Oncology
Lyon, France

Prof. Frederik
Marmé

University Medical Center
Gynecology
Mannheim, Germany

Prof. Marion
Kiechle

Technical University of Munich
Interdisciplinary Breast Center
Munich, Germany

Dr. Evelyn
Klein

Technical University of Munich
Interdisciplinary Breast Center
Munich, Germany

Full Program

Accessing cutting-edge precision oncology
through local testing

Chairs: Prof. Pascal Pujol & Prof. Carsten Denkert

Time Agenda Speakers
Ovarian Cancer
13:00 Introduction to the HRD round table Prof. Pascal Pujol
13:05 Optimal HRD ovarian cancer treatment – Are genomic tests interchangeable? Prof. Carsten Denkert, Prof. Benoît You, Prof. Frederik Marmé
13:25 How to implement local LoE1A HRD testing: experience of a center of excellence Prof. Carsten Denkert
13:40 Live Q&A
Breast Cancer
13:50 Real world prospective data support prognostic and predictive second-generation breast cancer signature performance Prof. Marion Kiechle, Dr. Evelyn Klein
14:10 Live Q&A
14:20 Conclusion Prof. Carsten Denkert
14:30 End of Symposium

Locations

United States
Europe
Japan